Page last updated: 2024-08-21

tristearin and betadex

tristearin has been researched along with betadex in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iannuccelli, V; Sala, N; Scalia, S; Tursilli, R1
Herrmann, S; Mohl, S; Siepmann, F; Siepmann, J; Winter, G2
Herrmann, S; Siepmann, F; Siepmann, J; Winter, G1
Coppi, G; Iannuccelli, V; Scalia, S1

Other Studies

5 other study(ies) available for tristearin and betadex

ArticleYear
Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-beta-cyclodextrin.
    International journal of pharmaceutics, 2006, Aug-31, Volume: 320, Issue:1-2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alkanes; beta-Cyclodextrins; Chalcones; Drug Compounding; Drug Stability; Emulsions; Excipients; Liposomes; Particle Size; Phosphatidylcholines; Photolysis; Propiophenones; Solubility; Sunscreening Agents; Time Factors; Triglycerides; Ultraviolet Rays

2006
Mechanisms controlling protein release from lipidic implants: effects of PEG addition.
    Journal of controlled release : official journal of the Controlled Release Society, 2007, Apr-02, Volume: 118, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Buffers; Chemistry, Pharmaceutical; Diffusion; Drug Carriers; Drug Compounding; Drug Implants; Drug Stability; Excipients; Freeze Drying; Humans; Hydrogen-Ion Concentration; Interferon alpha-2; Interferon-alpha; Kinetics; Lipids; Models, Chemical; Polyethylene Glycols; Recombinant Proteins; Solubility; Technology, Pharmaceutical; Triglycerides

2007
New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.
    Pharmaceutical research, 2007, Volume: 24, Issue:8

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Chemical Precipitation; Crystallization; Delayed-Action Preparations; Diffusion; Drug Implants; Drug Stability; Humans; Hydrogen-Ion Concentration; Interferon alpha-2; Interferon-alpha; Lipids; Microscopy, Fluorescence; Models, Theoretical; Polyethylene Glycols; Protein Structure, Secondary; Recombinant Proteins; Solubility; Spectroscopy, Fourier Transform Infrared; Triglycerides

2007
A novel mathematical model quantifying drug release from lipid implants.
    Journal of controlled release : official journal of the Controlled Release Society, 2008, Jun-24, Volume: 128, Issue:3

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Diffusion; Drug Implants; Excipients; Interferon-alpha; Kinetics; Models, Chemical; Polyethylene Glycols; Reproducibility of Results; Solubility; Technology, Pharmaceutical; Triglycerides; Water

2008
Microencapsulation of a cyclodextrin complex of the UV filter, butyl methoxydibenzoylmethane: in vivo skin penetration studies.
    Journal of pharmaceutical and biomedical analysis, 2011, Jan-25, Volume: 54, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Alkanes; beta-Cyclodextrins; Chalcones; Cyclodextrins; Drug Compounding; Emulsions; Filtration; Humans; Hydrogenation; Lipids; Microscopy, Electron, Scanning; Microspheres; Middle Aged; Molecular Structure; Particle Size; Phosphatidylcholines; Propiophenones; Skin; Skin Absorption; Sunscreening Agents; Surface-Active Agents; Triglycerides; Ultraviolet Rays

2011